Carasso Real Estate Ltd (TLV:CRSR)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,520.00
-20.00 (-0.56%)
Jul 31, 2025, 5:24 PM IDT
Orchard Therapeutics Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Net Income | 105.26 | 121.6 | 17.35 | 109.21 | 78.63 | -1.11 | Upgrade |
Depreciation & Amortization | 2.68 | 2.76 | 2.65 | 1.62 | 1.78 | 1.45 | Upgrade |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | -0.32 | -0.19 | -0.27 | 0.07 | Upgrade |
Asset Writedown & Restructuring Costs | -77.08 | -77.08 | -9.46 | -107.54 | -125.63 | -36.33 | Upgrade |
Loss (Gain) on Equity Investments | -74.57 | -87.71 | -19.25 | -26.14 | 0.81 | 4.83 | Upgrade |
Stock-Based Compensation | 5.01 | 6.26 | 9.51 | 6.88 | - | - | Upgrade |
Other Operating Activities | 38.71 | 41.35 | -8.36 | 54.62 | 62.77 | 8.85 | Upgrade |
Change in Accounts Receivable | -42.58 | 2.89 | -68.59 | 40.8 | 21.28 | -88.82 | Upgrade |
Change in Inventory | -155.41 | -117.8 | -67.85 | -15.35 | 24.06 | 11.49 | Upgrade |
Change in Accounts Payable | 5.61 | 0.94 | -6.57 | 19.56 | 1.88 | -12.38 | Upgrade |
Change in Unearned Revenue | 73.59 | 56.2 | -72.16 | 15.32 | 105.95 | -21.33 | Upgrade |
Change in Other Net Operating Assets | -8.04 | 22.52 | -36.54 | -5.73 | 6.69 | -4.61 | Upgrade |
Operating Cash Flow | -127 | -28.25 | -259.58 | 93.07 | 177.94 | -137.88 | Upgrade |
Operating Cash Flow Growth | - | - | - | -47.70% | - | - | Upgrade |
Capital Expenditures | -3.33 | -2.74 | -5.79 | -2.04 | -2.14 | -0.75 | Upgrade |
Sale of Property, Plant & Equipment | 0.94 | 0.68 | 1.12 | 0.67 | 0.98 | 0.42 | Upgrade |
Sale (Purchase) of Real Estate | -31.5 | -37.68 | -49.06 | -27.09 | -31.12 | -31.56 | Upgrade |
Investment in Securities | -176.87 | -187.64 | -111.48 | -103.68 | 24.68 | -6.59 | Upgrade |
Investing Cash Flow | -324.99 | -328.06 | -93.59 | -190.14 | -49.22 | -4.96 | Upgrade |
Short-Term Debt Issued | - | 14.55 | 90.65 | - | - | 180.86 | Upgrade |
Long-Term Debt Issued | - | 361.49 | 251.76 | 296.68 | 77.81 | 91.81 | Upgrade |
Total Debt Issued | 488.87 | 376.04 | 342.41 | 296.68 | 77.81 | 272.67 | Upgrade |
Short-Term Debt Repaid | - | - | - | -82.04 | -126.15 | -44.41 | Upgrade |
Long-Term Debt Repaid | - | -53.92 | -58.89 | -84 | -72.71 | -70.82 | Upgrade |
Total Debt Repaid | -21.55 | -53.92 | -58.89 | -166.05 | -198.86 | -115.22 | Upgrade |
Net Debt Issued (Repaid) | 467.32 | 322.12 | 283.52 | 130.64 | -121.05 | 157.45 | Upgrade |
Issuance of Common Stock | - | - | - | 161.48 | - | - | Upgrade |
Common Dividends Paid | - | - | -20 | - | - | - | Upgrade |
Other Financing Activities | - | - | - | - | - | -7 | Upgrade |
Financing Cash Flow | 467.32 | 322.12 | 263.52 | 292.12 | -121.05 | 150.45 | Upgrade |
Net Cash Flow | 15.34 | -34.18 | -89.65 | 195.04 | 7.68 | 7.6 | Upgrade |
Free Cash Flow | -130.32 | -30.99 | -265.37 | 91.03 | 175.79 | -138.63 | Upgrade |
Free Cash Flow Growth | - | - | - | -48.22% | - | - | Upgrade |
Free Cash Flow Margin | -25.32% | -6.23% | -59.79% | 14.72% | 30.35% | -39.18% | Upgrade |
Free Cash Flow Per Share | -2.39 | -0.56 | -4.90 | 1.88 | 4.35 | -3.43 | Upgrade |
Cash Interest Paid | 103.42 | 100.59 | 84.55 | 37.36 | 39.89 | 38.91 | Upgrade |
Cash Income Tax Paid | - | -0.21 | 0.8 | 0.85 | 9.12 | 7.56 | Upgrade |
Levered Free Cash Flow | -135.29 | -141.12 | -368.99 | 149.76 | 71.76 | - | Upgrade |
Unlevered Free Cash Flow | -81.82 | -91.37 | -323.08 | 189.44 | 100.87 | - | Upgrade |
Change in Net Working Capital | 133.6 | 145.37 | 370.71 | -131.76 | -67.3 | - | Upgrade |
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.